BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
SillaJen, Inc.
SillaJen, Inc.
Onward Therapeutics
Takeda
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute